SB 195 Summary

• Increases civil penalty authority for pharmacy violations to up to $1,000 per violation of chapter provisions, effective January 1, 2019.

• Adds fees for nonresident pharmacy certificate of registration holders to report changes in corporate officers, directors, name, ownership, or management ($60-$90 with $50 late fees).

• Requires all registered drug manufacturers and wholesalers to maintain systems identifying suspicious controlled substance orders and report them to the Drug Control Division, including copies of federal suspicious activity reports.

• Changes controlled substance inventory requirements from biennial to annual inventory, effective January 1, 2019.

• Mandates pharmacies maintain perpetual inventories of Schedule II controlled substances, reconciled monthly, with losses reported within 72 hours to the Commissioner of Consumer Protection.